TrialCancer2013

Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.

Brian H Kushner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.